IP litigation is a term encompassing various legal proceedings, including infringement lawsuits, oppositions, revocations, and cancellations, etc., in respect of patents, trademarks, designs, copyrights, and related IP rights.
Q:What is IP litigation?
A:
Q:What can be the result of IP litigation rulings for a company?
A:
If your company is found to infringe third-party IP rights, you may be enjoined from continuing to perform the activity that was found to infringe, and you may have to pay compensation for past infringements. Conversely, if you sue an infringer, you may obtain an injunction to stop the infringement and recover damages.
Q:How do I choose the right firm for IP litigation?
A:
The right firm for IP litigation must have both the legal and the technical expertise required to handle the specific subject. Therefore, you will want to work with a team of litigation lawyers and patent attorneys with a litigation background to ensure the best possible result.
Q:Why is it important in IP litigation to work with a team consisting of both advocates and patent attorneys?
A:
IP litigation involves both pure legal and technical expertise. Moreover, IP litigation is often intensive and requires handling by a team and not by a single individual. If your litigation is handled by a team, including experienced advocates and patent attorneys, they will bring the required expertise from both worlds to the case.
Relevant Articles
INTELLECTUAL PROPERTY LANDSCAPE IN ISRAEL 2023: UNVEILING DEVELOPMENTS AND CHALLENGES
In 2023, the intellectual property landscape in Israel had to deal with challenges created by the ongoing conflict. Despite these obstacles, interesting developments emerged, particularly in artificial intelligence and security, shaping a compelling trajectory for the year. Overall, it was an exceptionally intriguing year.
Read more....
The Luzzatto Group Wins a Landmark Ruling
Regarding Patent Term Extensions in Israel
Regarding Patent Term Extensions in Israel
On March 27, 2024, the Israeli District Court in Jerusalem rendered a significant ruling in a Novartis case concerning Patent Term Extensions (PTEs), which has broad implications for pharmaceutical patent owners. The court accepted an appeal against a decision of the Registrar of Patents to revoke a PTE, which establishes the principle that PTEs in Israel are linked to the active ingredient and not to the first pharmaceutical preparation used to file the PTE application.
Read more....
AI Determined Ineligible to be Considered an Inventor Under Israeli Law
In March, 2023, the Israeli Patent Office (ILPTO) issued a long-awaited administrative decision regarding the eligibility of an artificial intelligence (“AI”) computing system to serve as an “inventor” under Israeli patent law. The opinion ruled...
Read more....